Ambulatory patients with community-acquired pneumonia: The frequency of atypical agents and clinical course

American Journal of Medicine

Volumn 101, Issue 5, 1996, Pages 508-515

  Marrie, Thomas J ^a,e   Peeling, Rosanna W ^b   Fine, Michael J ^c   Singer, Daniel E ^d   Coley, Chris M ^d   Kapoor, Wishwa N ^c  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^b LAB CENTRE FOR DISEASE CONTROL   (Canada)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; AMBULATORY CARE; ARTICLE; BACTERIAL PNEUMONIA; FEMALE; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA; RADIOGRAPHY; TREATMENT OUTCOME; VIROLOGY; VIRUS PNEUMONIA;

ADULT; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; TREATMENT OUTCOME;

EID: 0030278374     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)00255-0     Document Type: Article

References (27)

1. Garibaldi RA. Epidemiology of community-acquired respiratory tract infections in adults: incidence, etiology, and impact. Am J Med. 1985;78:325-375.
2. Berntsson E, Lagergard T, Strannegard O, et al. Aetiology of community-acquired pneumonia in outpatients. Eur J Clin Microbiol. 1986;5:446-447.
3. Erard PH, Mosei F, Wenger A, et al. Prospective study on community-acquired pneumonia diagnosed and followed up by private practitioners. Abstracts of the 1991 Interscience Conference on Agents and Chemotherapy. Am Soc Microbiol. 1991;108:56A.
4. Woodhead MA, Macfarlane JT, McCracken JS, et al. Prospective study of the etiology and outcome of pneumonia in the community. Lancet. 1987;1:671-674.
5. Macfarlane JT, Colville A, Guion A, et al. Prospective study of aetiology and outcome of adult lower respiratory tract infections in the community. Lancet. 1993;341:511-514.
6. British Thoracic Society, the Public Health Laboratory Service. Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcomes. Q J Med. 1987; 239:195-220.
7. Ortqvist A, Hedlund J, Grillner L, Jalonen E. Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. Eur Respir J. 1990;3:1105-1113.
8. Blanquer J, Blanquer R, Borras R, Nauffald D. Etiology of community-acquired pneumonia in Valencie, Spain: a multicenter prospective study. Thorax. 1991;46:508-516.
9. Fang G, Fine M, Orloff J, Arisumi D, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy. Medicine. 1990;69:307-316.
10. Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: 5 year prospective study. Rev Infect Dis. 1989;11:586-599.
11. Macfarlane J. An overview of community-acquired pneumonia with lessons learned from the British Thoracic Society. Semin Respir Infect. 1994;9:153-165.
12. Shaw AB, Fry J. Acute infections of the chest in general practice. Br Med. 1955;2:1577-1586.
13. Everett MT. Major chest infections managed at home. Practitioner. 1983;227:1743-1754.
14. Dulake C, Selkon J. The incidence of pneumonia in the UK in pneumonia and pneumococcal infections. Royal Society Medicine London, Symposium Series No. 27;1982:87-94.
15. Mardh P, Hovelius B, Nordenfelt E, et al. The incidence and aetiology of respiratory tract infections in general practice - with emphasis on Mycoplasma pneumonia. Infection. 1976;4(suppl 1):405-475.
16. Cunha BA, Quintiliani R. The atypical pneumonias. A diagnostic and therapeutic approach. Postgrad Med. 1979;66:95-102.
17. Niederman MS, Bass JB Jr, Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis. 1993;148:1418-1426.
18. McDade JE, Shepard CC, Fraser DW, et al, for the Laboratory Investigative Team. Legionnaires' disease. Isolation of a bacterium and demonstration of its role in other respiratory disease. NEJM. 1977;297:1197-1203.
19. Cordes LG, Fraser DW. Legionellos̀is: Legionnaires' disease; Pontiac fever. Med Clin N Am. 1980;64:395-416.
20. Wang S-P, Kuo C-C, Grayston JT. Formalinized Chlamydia trachomatis organisms as antigens in the microimmunofluorescence test. J Clin Microbiol. 1979;10:259-261.
21. Marrie TJ, Grayston JT, Wang S-P, Kuo C-C. Pneumonia associated with the TWAR strain of Chlamydia. Ann Intern Med. 1987;106:507-511.
22. Kauppinen MT, Herva E, Kujala P, et al. The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland. J Infect Dis. 1995;172:1330-1335.
23. Almirall J, Morato I, Riera F, et al. Incidence of community-acquired pneumonia and Chlamydia pneumoniae infections. A prospective multicenter study. Eur Resp J. 1993;6:14-18.
24. McConnell CT Jr, Plouffe JF, File TM, et al, for the CBPIS Study Group. Radiographic appearances of Chlamydia pneumoniae (TWAR strain) respiratory infections. Radiology. 1994;192:819-824.
25. Ware JE, Sherbourne CD. The MOS 36-item Short Form Health Survey (SF.36):1. Conceptual framework and item selection. Med Care. 1992;30: 473-483.
26. Melbye H, Dale K. Interobservor variability in the radiographic diagnosis of adult outpatient pneumonia. Acta Radiologica. 1992;33:79-81.
27. Doern GV, Brueggmann A, Preston Holley H Jr, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother. 1996;40:1208-1213.